Skip to main content
Clinical Trials/KCT0009226
KCT0009226
Recruiting
未知

The effect of intraoperative remifentanil and sufentanil TCI on postoperative pain and postoperative opioid consumption in breast cancer surgery: A randomized controlled study

Chung-Ang University Gwangmyeong Hospital0 sites86 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Chung-Ang University Gwangmyeong Hospital
Enrollment
86
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 7, 2024
Last Updated
last year
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Chung-Ang University Gwangmyeong Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult female patient with American Society of Anesthesiologists physical status level 1\-2 scheduled for breast\-conserving surgery under general anesthesia

Exclusion Criteria

  • \- Under 18 years of age or over 70 years of age
  • \- ASA 3 or higher
  • \- BMI 35 or higher
  • \- Pregnant and lactating women
  • \- Patients with serious cardiovascular, liver, kidney, and hematological abnormalities
  • \- Patients with uncontrolled respiratory disease and moderate to severe pulmonary dysfunction
  • \- Those taking opioids, anticonvulsants, or antidepressants
  • \- Those with a history of hypersensitivity or serious side effects to drugs related to this study (opioids, acetaminophen, tramadol)
  • \- During the surgical procedure, the scope of surgery is reduced to a tumor resection or expanded to a total mastectomy.
  • \- Those who refused to participate in this study

Outcomes

Primary Outcomes

Not specified

Similar Trials